cancerresearch hashtag performance
#CancerResearch: Hopeful, vital, scientific, groundbreaking, fundraising, awareness, support, breakthroughs, cures, innovative, dedicated, inspiring, patient-focused, progress, donations, treatments, discoveries, resilience, community, education, prevention, research, advocacy, impact, collaborate, studies.
109.4k
Super Bowl cookies for our favorite team! 🏈✨ @St. Jude is a team worth supporting. It’s an honor to be a part of their team. Now go get your pin! #stjudeschildrenshospital #stjude #oneteam #cancer #cancerresearch #SuperBowl #superbowlcookies
8.7k
Help save the lives of cancer patients by donating to @thevfoundation ❤️ #linkinbio #VFoundationPartner #CancerResearch #CancerPatient
4.4k
“The Woman Who Might Change Cancer Treatment Forever” 🎤 “Did you know that one Black woman may have just changed cancer treatment forever?” 🧪 “Meet Dr. Hadiyah-Nicole Green—a physicist who developed a way to kill cancer cells using laser-activated nanoparticles!” 💡 “Unlike chemotherapy and radiation, her method ONLY targets cancer cells, leaving healthy ones unharmed. That means fewer side effects!” 📌 Quick Facts: • One of only 66 Black women to earn a Ph.D. in physics in the U.S. • The second Black woman to earn a Ph.D. in physics from UAB • Raised over $2M to make treatments affordable 🔥 “This could be the future of cancer treatment. More effective, less harmful!” 💬 “Tag someone who needs to know about this and help spread the word!” #Science #MedicalBreakthrough #Innovation #STEM #FutureOfMedicine #CancerResearch #CancerTreatment #BeatCancer #Nanotechnology #LaserTherapy #BlackExcellence #BlackWomenInSTEM #WomenInSTEM #BlackHistory #RepresentationMatters #DidYouKnow #ShareThis #FYP #LearnOnTikTok #MindBlown #fypシ
1.4k
Senator Elizabeth Warren Says PEOPLE Have To RAISE Their VOICES We unite voices to challenge Trump allowing an unelected billionaire, Elon Musk, to have control over every American's personal data and funding. Discover how grassroots movements and court actions are pushing back hard to protect small businesses and individual privacy from the richest man in the world. It's time to rally and demand accountability! #SenatorElizabethWarren #DataPrivacy #PublicPower #TaxReturns #SmallBusinessSupport #CourtActions #IRS #SpeakUp #ElonMusk #Privacy #NIHFunding #CancerResearch #UnelectedBillionaire #PersonalData #GrassrootsMovement #CommunityVoices #ProtectOurData
1.2k
There’s no better way for us to start Black History Month off than by honoring our founder, Dr. Hadiyah-Nicole Green Dr. Green is currently an assistant professor at Morehouse School of Medicine in the Department of Surgery and the recipient of $1.1 million grant from the U.S. Department of Veterans Affairs. Additionally, Dr. Green developed a 4-in-1 platform for early detection, imaging, targeting, and selective treatment of head and neck cancers. Dr. Green’s most noteworthy achievement is her development of a cancer treatment that uses lasers and nanotechnology to kill cancer in mice in just 15 days after a single 10-minute treatment with no observable side effects. She founded The as a 501(c)(3) non-profit to raise the funding for human clinical trials and ensure that this treatment can be made affordable for everyone. To learn more and support her efforts, visit OraLee.org to learn more and donate. Dr. Green’s ultimate goal is to translate these treatments out of the laboratory into humans and demonstrate efficacy in a variety of cancers, which could lead to saving some of the 8.8 million people who die each year from cancer worldwide. Help her continue to make history! We need more supporters, volunteers, and donors to make this vision a reality. We thank Dr. Green for all she has done, and we hope you will join us on the journey to health equity in cancer care. Please support our journey🙏🏾🙏🏾 👉🏾 Donate: OraLee.org 👉🏽 Donate Stocks: OraLee.org/stocks 👉🏽 Donate Crypto: OraLee.org/crypto 👉🏽 Donate Car: OraLee.org/car 👉🏾Text ORA to 71777 👉🏾CashApp/Venmo -- OraLeeFoundation #OraLee #DrHadiyahGreen #BlackHistoryMonth #CancerResearch #CancerAwareness #CancerSurvivor #CancerSucks #Family
1.0k
There is an immunotherapy drug, Dostarlimab, that has shown great results in cancer treatment. From my perspective, this dis-ease seems to stem from a breakdown of the immune system. Our immune system's job is to identify and destroy mutated cells before they develop into a serious condition, but for some people, this process fails. Dostarlimab works by blocking a specific protein (PD-1), allowing the immune system to recognize and eliminate harmful cancer cells that would typically evade detection. This is especially promising for individuals with certain cancer types, like endometrial or colorectal, where the drug has been remarkably effective in eliminating the cancer. You can find all of the research studies on today's show at StephenCabral.com/3290 #wellnesstips #functionalmedicine #naturopath #naturopathicmedicine #getheallthy #holistichealth #cancerresearch #cancertreatments #immunotherapy #immunehealth #Dostarlimab #stephencabral #cabralconcept
477.0
Politician doesn’t support feeeral funding for pediatric cancer research, says it should rely on philanthropy. #morethan4 #childhoodcancer #childhoodcancerresearch #pediatriccancer #pediatriccancerresearch #fyp #politics #federalfunding #cancerresearch #cancer #braintumor #braincancer #childloss
468.0
I am a firm believer in science. #resist #womenshealth #womensupportingwomen #cancerresearch #usnews #breastcancer #highrisk #lcis #womensrightsmatter #feminist #medicine #fyp #trending #uspolitics #science #realtalk #womenempowerment
432.0
The Girl Go Global™ devotional journal is for women who are ready to embrace their multi-layered lives with faith, know-how, and grit. It is designed to guide women through a process of self-discovery as they explore the depths of their identity in ways that uncover and unlock their God-given purpose. Whether it’s in 30, 90, or 365 days, allow this journal to grant you the time, space, and grace for the Lord to give you the answers you need for your future. The Ora Lee Smith Cancer Research Foundation is happy to announce that 20% of proceeds from the Girl Go Global™ book sales through April 16th, 2025 will be donated to our efforts to start human trials for 's laser-based cancer treatment! Thank you to Dr. Jasmine Leigh Morse for collaborating with us to change how cancer is treated! https://www.facebook.com/girlgoglobal https://www.youtube.com/channel/UCXnOHpl5iOQK8UHj2xl0Mlg Link to purchase the book: PRE-ORDERS AVAILABLE NOW Terms: 20% net for every book sold from her Girl Go Global™ website starting January 16th, 2025 - April 16th, 2025. #CancerResearch #GirlGoGlobal #SupportCancerResearch #OraLeeSmithFoundation #PurposeDriven
428.0
If you have cancer or a loved one has cancer, you should really be concerned. #cancer #cancertreatment #cancerfighter #cancerresearch #trumpadministration #clinicaltrials #healthagencies #fundcancerresearch #republicans #evil #doma #musk #muskyfishing #nih #cancercure #doge #dogenrichment #douchedoge #douchebag #nationalinstituteofhealth #cancersucks @The Democratic Party @Democrats Of TikTok @cancer research @ks_institutes_of_health @Cancer Cure Quest
320.0
In 2025, Russia will launch a groundbreaking mRNA cancer vaccine, available to patients for free. Confirmed by Andrey Kaprin, head of Russia's Radiology Medical Research Center, early trials show promising results, with the vaccine slowing tumor growth and spread. With AI speeding up personalized vaccine development, the production time could be reduced to just under an hour. Unlike traditional vaccines, this mRNA vaccine teaches the immune system to target tumor-specific antigens, and it’s tailored to each patient. Russia joins other companies like Moderna, Merck, and BioNTech in this innovative field! #CancerResearch #mRNAVaccine #innovation #4ourweeks #advice #business #money #businessidea #inspiration #entrepreneurquotes #businessbuilding #dailymotivationquotes #success #discipline #financialfreedom #fyp #advice #business #money #businessidea #quoteoftheday #inspiration #entrepreneurquotes #warrenbuffettquotes #entrepreneurshipquotes #dailymotivationquotes #businessbuilding #bookreader #bookreviewer #financialfreedom #wealthbuilding #booklovers #bookquotes #elonmusk #elonmuskquotes #elonmuskquote #markzuckerberg #elonmuskisagenius #entrepreneurmotivation #entrepreneur101 #entrepreneurship101 #entrepreneurshipfacts #entrepreneurshipmindset #businesstips101 #businessmotivation #businesspassion #businessinsider #businesstips #businessintelligence #elon #businessmindset101 #billionairemindset #business101 #billionaireclub #billionaireminds #billionairemindset #wealthymindset
214.0
OS Therapies (NYSE-A: OSTX) received positive news from the U.S. Patent & Trademark Office (USPTO), a Notice of Allowance for a patent covering the commercial manufacturing methods of OST-HER2, with market exclusivity extended into 2040. This milestone supports the Company’s ongoing preparation for a Biologics Licensing Application (BLA) submission to the FDA, and gaining conditional or accelerated approval in 2025. OS Therapies is a B2i Digital Featured Company. See their profile and learn more about OS Therapies at https://b2idigital.com/os-therapies-1. Highlights from the announcement include: · The patent provides market exclusivity in the U.S. until 2040 for all therapeutic indications of OST-HER2. · The Company is preparing for FDA discussions following positive Phase 2b trial results in osteosarcoma. · A Priority Review Voucher (PRV), valued at approximately $150 million based on recent transactions, may be available upon FDA approval. OST-HER2 is an immunotherapy designed to prevent recurrence of lung metastatic osteosarcoma. It has received Fast Track, Orphan Drug, and Rare Pediatric Disease designations from the FDA and has also shown promising results in breast cancer models. OS Therapies is advancing its tunable Antibody Drug Conjugate (tADC) platform, which features proprietary silicon linker technology for delivering tailored antibody-linker-payload therapies targeting solid tumors. See the full announcement at https://ir.ostherapies.com/news-events/press-releases/detail/45/os-therapies-receives-patent-notice-of-allowance-from-u-s. Led by CEO Paul Romness and a highly experienced executive team, including Chris Acevedo (CFO), Robert Petit (Chief Medical and Scientific Officer), Jack Doll (Chief of Staff), and Gerald Commissiong (Chief Business Officer), OS Therapies is focused on driving its pipeline forward to deliver potentially transformative treatments for osteosarcoma and other hard-to-treat cancers. Learn more about OS Therapies’ work at https://www.ostherapies.com/ and visit B2i Digital for updates. For investor-related questions, please visit OS Therapies’ Investor Relations page or email irpr@ostherapies.com. #OSTherapies #Immunotherapy #CancerResearch #B2iDigital DISCLAIMER: The management of B2i Digital owns 2,000 shares of unrestricted OSTX stock purchased in the open market as of February 20, 2025. This post is not intended to solicit the sale of OSTX or any security, and it is not intended to offer any opinion on OSTX as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the full disclaimer in the Risks and Disclosures section of https://b2idigital.com/os-therapies-1.
15.0
“A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die. This new ability to trigger programmed cell death could open the door for improved cancer treatments. The findings were published Oct. 14 in the Nature journal Cell Death & Differentiation” “Death receptors do precisely what their name implies — when targeted, they trigger programmed cell death of tumor cells. They offer a potential workaround that could simultaneously kill tumor cells and pave the way for more effective immunotherapies and CAR T-cell therapy Developing drugs that boost death receptor activity could provide an important weapon against tumors. However, though drug companies have had some success targeting the Death Receptor-5, no Fas agonists have made it into clinical trials. These findings could potentially change that “ https://health.ucdavis.edu/cancer/ https://health.ucdavis.edu/news/headlines/researchers-identify-switch-to-activate-cancer-cell-death/2023/10 #cancer #cancersucks #cancerresearch #LearnOnTikTok #cancercure #thebodycanhealitself
start an influencer campaign that drives genuine engagement
Technology
Fastest Growing